In flight, how should an acute severe asthma attack be managed?

Prepare for the Flight Surgeon Module D Test. Study with multiple choice questions and detailed explanations. Boost your readiness now!

Multiple Choice

In flight, how should an acute severe asthma attack be managed?

Explanation:
When a person has an acute severe asthma attack, the primary goal is to rapidly reverse bronchoconstriction and keep oxygen levels adequate while arranging for definitive care. The most effective in-flight approach is to give a rapid-acting inhaled bronchodilator (short-acting beta-agonist) via a metered-dose inhaler with a spacer or via nebulizer, along with supplemental oxygen to maintain safe oxygenation. If the attack persists, systemic steroids are added to reduce the inflammatory response and help shorten the episode. The patient should be landed as soon as practical so they can receive formal evaluation and treatment. Epinephrine injections are not the standard initial treatment for an acute asthma attack in flight. They carry systemic risks and are reserved for situations such as anaphylaxis or a life-threatening attack unresponsive to standard bronchodilators, where the benefits may outweigh the risks.

When a person has an acute severe asthma attack, the primary goal is to rapidly reverse bronchoconstriction and keep oxygen levels adequate while arranging for definitive care. The most effective in-flight approach is to give a rapid-acting inhaled bronchodilator (short-acting beta-agonist) via a metered-dose inhaler with a spacer or via nebulizer, along with supplemental oxygen to maintain safe oxygenation. If the attack persists, systemic steroids are added to reduce the inflammatory response and help shorten the episode. The patient should be landed as soon as practical so they can receive formal evaluation and treatment.

Epinephrine injections are not the standard initial treatment for an acute asthma attack in flight. They carry systemic risks and are reserved for situations such as anaphylaxis or a life-threatening attack unresponsive to standard bronchodilators, where the benefits may outweigh the risks.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy